The marketing of 5-hydroxytryptamine: depression or anxiety?
Healy
D
D
Sub-Department of Psychological Medicine, North Wales Hospital, Denbigh, Clwyd.
D000928:Antidepressive Agents / Q000627:therapeutic use*; D001008:Anxiety Disorders / Q000188:drug therapy* / Q000503:physiopathology / Q000523:psychology; D001921:Brain / Q000187:drug effects / Q000503:physiopathology; D003866:Depressive Disorder / Q000188:drug therapy* / Q000503:physiopathology / Q000523:psychology; D006801:Humans; D011358:Product Surveillance, Postmarketing; D011985:Receptors, Serotonin / Q000502:physiology; D012702:Serotonin Antagonists / Q000627:therapeutic use*
D000928:Antidepressive Agents; D011985:Receptors, Serotonin; D012702:Serotonin Antagonists